110.1
[1]. J Davies, et al. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP binding sites on brain membranes and anticonvulsant activity. Brain Res. 1986 Sep 10;382(1):169-73.
[2]. Adrian Flierl, et al. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication. PLoS One. 201 Nov 12;9(11):e11213.
[3]. Alyssa M A Toda, et al. Regulation of AMPA receptor phosphorylation by the neuropeptide PACAP38. Proc Natl Acad Sci U S A. 201 May 26;112(21):6712-7.
[]. Evita Bothur, et al. Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1. Nat Commun. 201 Oct 13:6:876.
[]. Hyung Sook Kim, et al. Validation of cyclooxygenase-2 as a direct anti-inflammatory target of -O-methylhonokiol in zymosan-induced animal models. Arch Pharm Res. 201;38():813-2.
H31-H319-H33
P261-P26-P271-P280-P302+P32-P30+P30-P362+P36-P0-P01